Proposed 2027 Medicare Lab Fee Cuts: Flawed Data, Real Consequences
The Centers for Medicare and Medicaid Services (CMS) just announced a proposed $1 billion in savings for laboratory services. What may first appear as a “good news” headline for the general public is in fact potentially devastating for providers of laboratory services.
The announcement notes current Medicare payment rates are approximately 16 percent higher than those paid by commercial insurance. The problem? Data used for this analysis represents less than 2 percent of labs paid under Medicare Part B in 2024, with thousands of independent labs failing to report their payments. As a result, an incomplete database has resulted in reductions in Medicare fees far greater than Congress intended when establishing the Protecting Access to Medicare Act (PAMA) in 2014.
There is a limited time for Congressional action to stop proposed fee cuts for 2027 and the 30-day window for public comments is still open so we encourage providers (and their patients) to contact their members of Congress to “stop the cuts” and support the RESULTS Act (H.R. 5269/S. 2761). The RESULTS has widespread bipartisan and bicameral support but still needs Congressional approval. CMS finalizes rates in November 2026 for 2027 implementation.
Fact sheets, sample letters and more information are available at www.StopLabCuts.org.
